AstraZeneca will invest $3.5 billion in the U.S. by 2026, creating jobs and expanding facilities.

AstraZeneca plans to invest $3.5 billion in the U.S. by 2026, aiming to expand research and manufacturing. This includes a $2 billion investment to create over 1,000 high-skilled jobs and establish facilities like a new R&D center in Massachusetts and a biologics manufacturing site in Maryland. The investment reflects the company's strategy to boost its U.S. operations, its largest market, and reach $80 billion in revenue by 2030.

November 12, 2024
24 Articles

Further Reading